Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M24 for a violation of the Anti-Doping Rules. During an athletics event on September 27, 2009, a sample was taken for doping test purposes. The sample tested positive on prednisone and prednisolone which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list. They are regarded as specified substances.

History
The respondent had used a pharmaceutical product to heal an ear infection, this product was the cause of the positive test. However she failed to provided evidence of the justification for therapeutic purposes of the use of the medicine.

Decision
1. The sanction is a period of ineligibility of three months in which respondent can't take part in competition or sport manifestations organized by the FFA.
2. The decision (a warning) dated December 2, 2009, by the disciplinary committee of the FFA should be modified.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

Facts
The French Athletics Federation (Fédération Française d'Athlétisme, FFA) charges respondent M23 for a violation of the Anti-Doping Rules. During an athletics event on September 26, 2009, a sample was taken for doping test purposes. The sample tested positive on a metabolite of budenoside which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list. It is regarded as a specified substance.

History
Respondent used several pharmaceutical products to treat allergies, rhinitis and asthma. These product are the cause of the positive test. He has a certificate from his physician to state his condition.

Decision
1. The sanction is a period of ineligibility of six months in which respondent can't take part in competition or sport manifestations organized by the FFA..
2. The decision (1 month period of ineligibility) dated December 2, 2009, by the disciplinary committee of the FFA should be modified.
3. The period of ineligibility will be reduced by the period already served by the decision of December 2, 2009.
4. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.

Facts
The French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme, FFHMFAC) charges respondent M22 for a violation of the Anti-Doping Rules. During a mixed contest on June 20, 2009, a sample was taken for doping test purposes. The sample showed the presence of the prohibited substances cannabis and  metandienone.

History
The respondent didn't provide any explanation about how the prohibited substances had entered his body.

Decision
1. The sanction is a four years period of ineligibility in which respondent can't take part in competition or manifestations organized or authorized by French sport federations.
2. All the individual results obtained at the event on June 20, 2009, are cancelled. Medals, points and prizes are withdrawn.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

Facts
The French Sailing Federation (Fédération Française de Voile, FFV) charges respondent M21 for a violation of the Anti-Doping Rules. During a sailing event on September 9, 2009, a sample was taken for doping test purposes. Analysis of the sample showed the presence of a metabolite of cannabis. Cannabis is a prohibited substance according the World Anti-Doping prohibited list, it is regarded as a specified substance.

History
The respondent used the prohibited substance a week before the doping test in a recreational setting. There was no intention to enhance sport performance.

Decision
1. The decision (3 months period of ineligibility), dated December 1, 2009, of the disciplinary committee of the FFV should be modified.
2. The sanction is a period of ineligibility of six months in which respondent can't take part in competition or manifestations organized or authorized by the FFV.
3. The period of ineligibility will be reduced with one month which is the period already served in by the decision, dated February 1, 2010, of the disciplinary committee of the FFV.
4. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.

Affidavit Jean-Pierre Verdy [USADA vs Lance Armstrong October 10, 2012] September 10, 2012

Mr. Jean-Pierre Verdy is Testing Director of the Agence française de lute contre le dopage (AFLD), the French Anti-Doping Agency.

Mr Verdy testified to USADA about a reported anti-doping rule violation committed by the cyclist Lance Armstrong on 17 March 2009 in Saint-Jean Cap Ferrat, France.

On that day a French doping control officer notified Mr. Armstrong to provide a out-of-competition sample. However after the notification Mr. Armstrong went inside his home and came out of the house twenty minutes, after repeated requests by telephone. Hereafter he provided a sample to the doping control officer.

In the AFLD report on the 2009 Tour de France, for which the French agency was given the mandate by the Union Cycliste Internationale to carry out doping control tests, the Astana team, of which Lance Armstrong was a member, benefited from privileged information or timing advantages during doping control tests.

Facts
The French Hockey Federation (Fédération Française de Hockey, FFHockey) charges respondent M18 for a violaton of the Anti-Doping Rules. During a match on April 26, 2009 a sample was taken for doping test purposes. The analysis of the sample showed the presence of budesonide. This substances is prohibited according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent had uses an inhalator to treat asthma. He did mention this during the doping control. He uses it against his allergy for pollen. He ha medical certificates for this condition and a report concerning an exploration of his respiratory functionality. There was no intention to enhance his sport performance.

Decision
1. The decision, dated July 23, 2009, of the disciplinary committee should be modified.
2. The respondent is acquitted.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Affidavit Lory Testasecca [USADA vs Lance Armstrong October 10, 2012] September 23, 2012

Lory Testasecca testified to USADA about the conversations she had with her close friend Betsy Andreu who also testified to USADA.
Lory Testasecca stated that Betsy was upset after her visit with Mr. Andreu to Lance Armstrong in the Indiana University Hospital on 27 October 1996 where Armstrong was for a cancer treatment. In a full room she heard Lance Armstrong confessing to his doctors that he had used performance enhancing drugs. Also Betsy Andreu shared her concern about the use of doping by Mr. Andreu as professional cyclist.

Facts
The French Ice Hockey Federation (Fédération Française de Hockey sur Glace, FFHG) charges respondent M17 for a violaton of the Anti-Doping Rules. During a match on February 10, 2009 a sample was taken for doping test purposes. The analysis of the sample showed the presence of a prednisolone and prednisone. These substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list and are regarded as specified substances.

History
The respondent had used medication to treat an acute asthma attack with a bronchial infection on advice of his physician. He is still under treatment. He did mention his medication on the doping control form.

Decision
1. The sanction is a period of ineligibility of one month in which the respondent can't take place in competition or manifestations organized or authorized by the FFHG.
2. The period of ineligibility will be reduced by the period already served by the decision dated July 15, 2009, from the appeal committee of the FFHG.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Affidavit Paul Scott [USADA vs Lance Armstrong October 10, 2012]
October 9, 2012

Mr. Paul Scott is founder, President and Chief Science Officer of Scott Analytics, a company that provides internal anti-doping programs for professional cyclists and other non cycling events.

Mr. Scott stated to USADA that he helped Floyd Landis to come clean about his use of doping during his cycling career.
On behalf of Floyd Landis he contacted USADA and provided them with statements from Landis about systemic doping on the U.S. Postal Service team, his involment and the involment of several elite cyclists, medical doctors and officials.
Hereafter Floyd Landis had meetings in person with USADA where he relayed the previous information, and additional information regarding his experiences and personal knowledge of doping in cycling.

Facts
The French Federation of Tamborello (Fédération Française de Jeu de Balle au Tambourin, FFJBT) charges respondent M16 for a violation of the Anti-Doping rules. During a match on August 16, 2009, a sample was taken for doping test purposes. Analysis of the sample showed a high testerone on epitestosterone ratio and a spectromatic analysis showed testosterone of exogenous origin. Exogenous testosterone is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The positive test was caused by an intramuscular injection to treat a disease from which he suffers several years. He has statements and reports of blood regarding his condition.

Decision
1. The decision (5 months period of ineligibility), dated December 1, 2009, of the disciplinary committee of the FFJBT should be modified.
2.The repondent is acquitted.
3. The sanction starts on the date of the notification.
4. The decision will be published and sent to the parties involved.